Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
236 | 3 | PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL | 47933 |
282 | 2 | PROSTATE CANCER//PROSTATE//ANDROGEN RECEPTOR | 19095 |
24532 | 1 | UNIT 173//EGF R AND VEGF R PHOSPHORYLATION//M1B PROSTATE CANCER | 332 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | UNIT 173 | address | 281438 | 4% | 23% | 13 |
2 | EGF R AND VEGF R PHOSPHORYLATION | authKW | 189859 | 1% | 100% | 2 |
3 | M1B PROSTATE CANCER | authKW | 189859 | 1% | 100% | 2 |
4 | EGF EGFR SYSTEM | authKW | 126571 | 1% | 67% | 2 |
5 | AUTOCRINE GROWTH REGULATION | authKW | 122049 | 1% | 43% | 3 |
6 | AEE788 | authKW | 101252 | 1% | 27% | 4 |
7 | ADENCARCINOMA | authKW | 94930 | 0% | 100% | 1 |
8 | ANTI CANCERTHERAPY | authKW | 94930 | 0% | 100% | 1 |
9 | APOPTOTIC NECROTIC DEATH | authKW | 94930 | 0% | 100% | 1 |
10 | ASL OLBIA | address | 94930 | 0% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 4182 | 58% | 0% | 192 |
2 | Urology & Nephrology | 2163 | 24% | 0% | 79 |
3 | Endocrinology & Metabolism | 215 | 11% | 0% | 36 |
4 | Pathology | 155 | 7% | 0% | 22 |
5 | Andrology | 26 | 1% | 0% | 2 |
6 | Cell Biology | 19 | 6% | 0% | 20 |
7 | Medicine, Research & Experimental | 3 | 2% | 0% | 8 |
8 | Chemistry, Medicinal | 1 | 1% | 0% | 4 |
9 | Integrative & Complementary Medicine | 1 | 0% | 0% | 1 |
10 | Genetics & Heredity | 0 | 2% | 0% | 6 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | UNIT 173 | 281438 | 4% | 23% | 13 |
2 | ASL OLBIA | 94930 | 0% | 100% | 1 |
3 | CATTEDRA RADIOTER IAA | 94930 | 0% | 100% | 1 |
4 | CEDICINE | 94930 | 0% | 100% | 1 |
5 | GEN THER EUT CLIN PHARMACOKINETCHUO KU | 94930 | 0% | 100% | 1 |
6 | MED INFORM SCI | 94930 | 0% | 100% | 1 |
7 | PHARMACEUT SERVSECT UROL SURG | 94930 | 0% | 100% | 1 |
8 | PROSTATE VGH | 94930 | 0% | 100% | 1 |
9 | PROTEOMEDIX AG | 94930 | 0% | 100% | 1 |
10 | QUEENSLAND BRANCH | 94930 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROSTATE | 16047 | 8% | 1% | 28 |
2 | TARGETED ONCOLOGY | 5264 | 2% | 1% | 5 |
3 | CLINICAL CANCER RESEARCH | 2719 | 6% | 0% | 21 |
4 | NEOPLASIA | 1946 | 2% | 0% | 6 |
5 | CLINICAL GENITOURINARY CANCER | 1927 | 1% | 1% | 4 |
6 | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 1171 | 2% | 0% | 5 |
7 | JOURNAL OF BONE ONCOLOGY | 770 | 0% | 1% | 1 |
8 | CANCER AND METASTASIS REVIEWS | 681 | 1% | 0% | 3 |
9 | HORMONES & CANCER | 563 | 0% | 1% | 1 |
10 | JOURNAL OF UROLOGY | 555 | 4% | 0% | 13 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |